Table 1 Demographic characteristics of 15 patients with metastatic melanoma
Patient ID | Sex | Primary site | Stage (diagnosis) | Breslow (mm) | Ulceration | Mitosis | BLS/CLND | Stage (enrolment) | BRAF Status | Metastastic Sites |
|---|---|---|---|---|---|---|---|---|---|---|
1 | M | Trunk | IIIA | 0.9 | N | > 1 | N1a | IV – M1a(0) | WT | Sc |
2 | M | Arm | IIIB | 1.9 | Y | > 1 | N2a | IV – M1b(0) | V600E | N; L; Sc |
3 | F | Arm | IIIB | 1.2 | N | > 1 | N2b | IV – M1a(0) | WT | N |
4 | F | Arm | IIIB | 1.5 | Y | < 1 | N2b | IV – M1c(0) | V600E | Li; Pe; Ad; Mu |
5 | M | Trunk | IV | 1.6 | Y | > 1 | ND | IV – M1b(1) | V600E | L |
6 | M | Trunk | IIIC | 11 | Y | > 1 | N2c | IV – M1c(1) | V6003 | L; N; Bo; Li; Br |
7 | F | Leg | IIIB | 2.1 | N | > 1 | N1a | IV – M1b(0) | V600E | N; L; Sc |
8 | M | H/N | IV | 4.8 | Y | > 1 | ND | IV – M1c(0) | V600E | L; Li; Pe; Mu; Sc |
9 | M | H/N | IIIC | 5.4 | Y | > 1 | N1b | IV – M1d(−) | V600E | Br; L; Ad; Sc; N |
10 | M | Trunk | IV | 2.4 | Y | > 1 | ND | IV – M1c(−) | V600E | N; Bo; Sc; Mu |
11 | F | Leg | IIIB | 3.6 | N | < 1 | N2a | IV – M1c(0) | V600E | N; Li; Bo; Sc |
12 | F | Trunk | IIIC | 1.6 | Y | > 1 | N3c | IV – M1c(1) | WT | L; N; Sc; Sp |
13 | F | U | IV | – | – | – | ND | IV – M1d(0) | V600E | L; Br; Sc; Sp |
14 | M | Leg | IV | 7 | Y | > 1 | ND | IV – M1c(0) | V600E | N; L; Li; Pe |
15 | M | Leg | IIIC | 5.1 | Y | > 1 | N1a | IV – M1c(−) | V600E | N; Sc; Br; Bo; O |